Modulation of IFN-γ, TNF-α, IL-10 and IL-12 production by artesunate in mitogen treated splenocytes

International Journal of Tropical Medicine

Volumn 4, Issue 2, 2009, Pages 65-69

  Gumede, B ^a   Waako, P J ^b   Folb, P I ^a   Ryffel, B ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MAKERERE UNIVERSITY   (Uganda)

Author keywords

Artesunate; Chloroquine; Cytokines; Immunomodulation; Lps; Malaria

Indexed keywords

EID: 79955960187     PISSN: 18163319     EISSN: 1818779X     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Barennes, H., N. Nagot, I. Valea, T. Koussoube-Balima, A. Ouedraogo, T. Sanou and S. Ye S., 2004. A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso. Trop. Med. Int. Health, 9 (4): 438-444. www.ncbi.nlm.nih.gov/pubmed/15078261.
2. Breman, J.G., M.S. Alilio and A. Mills, 2004. Conquering the intolerable burden of malaria: What's new, what's needed: A summary. Am. J. Trop. Med. Hyg., 71: (2 Suppl): 1-15. www.ncbi.nlm.nih.gov/pubmed/ 15331814.
3. Bojang, K., G. Scheider and S. Forck, 1998. A trial of Fansidar plus chloroquine or Fansidar alone for the treatment of uncomplicated malaria in Gambian children. Trans. R. Soc. Trop. Med. Hyg., 92: 73-76. www.ncbi.nlm.nih.gov/pubmed/9598454.
4. Davis, T.M., H.A. Karunajeewa and K.F. Ilett, 2005. Artemisinin-based combination therapies for uncomplicated malaria. Med. J. Aust, 21; 182(4): 181-185.ww.ncbi.nlm.nih.gov/pubmed/15720175.
5. Dean, T., A. Dewey, A. Bara, T.J. Lasserson and E.H. Walters, 2003. Chloroquine as a steroid sparing agent for asthma. Cochrane Database Syst. Rev. (4): CD003275. ww.ncbi.nlm.nih.gov/pubmed/14583965.
6. Giao, P.T., T.Q. Binh, P.A. Kager, H.P. Long, N. Van Thang, N. Van Nam and de P.J. Vnes, 2001. Artemisinin for treatment of uncomplicated falciparum malaria: Is there a place for monotherapy? Am. J. Trop. Med. Hyg., 65 (6): 690-695. www.ncbi. nlm.mh.gov/pubmed/11791958.
7. Ittarat, W., R. Udomsangpetch, K.T. Chotivanich and S. Looareesuwan, 1999. The effects of quinine and artesunate treatment on plasma tumor necrosis factor levels in malaria-infected patients. Southeast Asian J. Trop. Med. Public Health, 30 (1): 7-10. ww.ncbi.nlm.nih.gov/pubmed/10695778.
8. Kwiatkowski, D. and C. Bate, 1995. Inhibition of tumour necrosis factor production by antimalarial drugs used in cerebral malaria. Trans. Roy. Soc. Trop. Med. Hyg., 89:215-216. www.ncbi.nlm.nih.gov/pubmed/7778153.
9. Kwiatkowski, D., M.E. Molyneux, S. Stephens, N. Curtis, N. Klein, P. Pointaire, M. Smith, R. Allan, D.R. Brewster, G.E. Grau and B.M. Greenwood, 1993. Anti-TNF therapy inhibits fever in cerebral malaria. Q. J. Med., 86: 91-98.www.ncbi.nlm.nih.gov/pubmed/ 8329024.
10. Landewe, R, A. Miltenburg, M. Verdonk and C. Verweij, 1995. Chloroquine inhibits T-cell proliferation by interfering with IL-2 production and responsiveness. Clin. Exp. Immunol., 102:144-151. www.ncbi.nlm.nih.gov/pubmed/7554381.
11. Lin, X., F. Cheng, L. Zhang, Q. Song and H. Zhang, 1984. Comparison of the immunosuppression of Qinghaosu and its derivatives. Shanghai J. Immunol., 4: 348-351.
12. Nguyen, D.S., B.H. Dao, P.D. Nguyen, V.H. Nguyen, N.B. Le, V.S. Mai and S.R. Meshmck, 1993. Treatment of malaria in Vietnam with oral artemisinin. Am. J. Trop. Med. Hyg., 48 (3): 398-402. www.ncbi.nlm.nih.gov/pubmed/8470777.
13. Paton, N.I. and J. Aboulhab, 2005. Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: Safety, efficacy and resistance profile after 144 weeks. HIV Med., 6 (1): 13-20. www.ncbi.nlm.nih.gov/pubmed/15670247.
14. Picot, S., A. Nkwelle Akede, J.F. Chaulet, E. Tetanye, P. Ringwald, J.M. Prevosto, C. Boudin and P. Ambroise-Thomas, 1997. Chloroquine self-treatment and clinical outcome of cerebral malaria in children. Clin. Exp. Immunol, 108 (2): 279-283. www.ncbi.nlm.nih.gov/pubmed/9158098.
15. Picot, S., F. Peyron, A. Donadille, J. Vuillez, G. Barbe and P. Ambroise-Thomas, 1993. Chloroquine-induced inhibition of the production of TNF, but not IL-6, is affected by disruption of iron metabolism. Immunology, 80: 127-133. www.ncbi.nlm.nih.gov/ pubmed/8244453.
16. Qian, R., Z. Li, J. Yu and D. Ma, 1981. Immunomodulating action and antivirus effect of Qinghaosu. Trad. Chin. Med. J., 6: 63-66.
17. Qian, R., Z. Li, M. Xie, L. Xu, M. Liang and X. Liu, 1987. Influence of Qinghaosu on the phagocytosis function of macrophages. Chin. Trad. Herbal Drug, 18: 14-17.
18. Reeves, G.E., M.J. Boyle, J. Bonfield, P. Dobson and M. Loewenthal, 2004. Impact of hydroxychloro-quine therapy on chronic urticaria: Chronic autoimmune urticaria study and evaluation. Int. Med. J., 34 (4): 182-186. www.ncbi.nlm.mh.gov/pubmed/1508 6698.
19. Sun, X., S. Xie, Z. Long, W. Zhang and Y. Tu, 1991. Experimental research on the immune suppression of Qinghaosu and its derivatives. Chin. J. Integrated Trad. West Med., 11: 37-38.
20. Tawfik, A., S. Bishop, A. Ayalp and F. El-Feraly, 1990. Effects of artemisinin, dihydroartemisinin and arteether on immune response of normal mice. Int. J. Immunopharmacol., 12: 385-389. www.ncbi.nlm.nih.gov/pubmed/2202689.
21. Teja-Isavadharm, P., G. Watt, C. Eamsila, K. Jongsakul, Q. Li, G. Keeratithakul, N. Sirisopana, L. Luesutthiviboon, T.G. Brewer and D.E. Kyle, 2001. Comparative pharmacokinetics and effect kinetics of orally administered artesunate in healthy volunteers and patients with uncomplicated falciparum malaria Am. J. Trop. Med. Hyg., 65 (6): 717-721. ww.ncbi.nlm.mh.gov/pubmed/11791963.
22. Walker, O., A.H. Dawodu, A.A. Adeyokunnu, L.A. Salako and G. Alvan, 1983. Plasma chloroquine and des ethyl chloroquine concentrations in children during and after chloroquine treatment for malaria. Br. J. Clin. Pharmacol., 16 (6): 701-705. www.ncbi.nlm.nih.gov/pubmed/6661356.
23. White, N.J., 1985. Clinical pharmacokinetics of antimalarial drugs. Clin. Pharmacokinet, 10 (3): 187-215. www.ncbi.nlm.nih.gov/pubmed/3893840.
24. Yang, S.X., S.S. Xie, H.L. Gao and Z.Z. Long, 1993. Artemisinin and its derivatives enhance T lymphocyte-mediated immune responses in normal mice and accelerate immunore constitution of mice with syngeneic bone marrow transplantation. Clin. Immunol. Immunopathol., 69 (2): 143-148. www.ncbi.nlm.nih.gov/pubmed/8403551.
25. Ye, X., D. Cheng and Y. Wang, 1982. Effect of Qinghaosu on phagocytosis of peritoneal macrophages in mice. Acta Beijing Med. Coll., 14: 141-142.